Vericel Corp (VCEL)
48.30
-0.34
(-0.71%)
USD |
NASDAQ |
May 10, 10:05
Vericel Free Cash Flow: 2.036M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.036M |
| December 31, 2023 | 7.798M |
| September 30, 2023 | 11.40M |
| June 30, 2023 | 13.49M |
| March 31, 2023 | 8.651M |
| December 31, 2022 | 10.09M |
| September 30, 2022 | 13.80M |
| June 30, 2022 | 12.28M |
| March 31, 2022 | 13.77M |
| December 31, 2021 | 21.12M |
| September 30, 2021 | 21.83M |
| June 30, 2021 | 24.86M |
| March 31, 2021 | 18.72M |
| December 31, 2020 | 14.95M |
| September 30, 2020 | 7.468M |
| June 30, 2020 | 10.13M |
| March 31, 2020 | -5.752M |
| December 31, 2019 | -9.799M |
| September 30, 2019 | -10.55M |
| June 30, 2019 | -16.52M |
| March 31, 2019 | -3.389M |
| December 31, 2018 | -3.09M |
| September 30, 2018 | -5.008M |
| June 30, 2018 | -11.66M |
| March 31, 2018 | -11.28M |
| Date | Value |
|---|---|
| December 31, 2017 | -14.69M |
| September 30, 2017 | -24.22M |
| June 30, 2017 | -22.88M |
| March 31, 2017 | -23.22M |
| December 31, 2016 | -21.31M |
| September 30, 2016 | -16.03M |
| June 30, 2016 | -13.10M |
| March 31, 2016 | -12.59M |
| December 31, 2015 | -15.77M |
| September 30, 2015 | -18.63M |
| June 30, 2015 | -25.63M |
| March 31, 2015 | -26.03M |
| December 31, 2014 | -26.24M |
| September 30, 2014 | -23.59M |
| June 30, 2014 | -19.24M |
| March 31, 2014 | -17.88M |
| December 31, 2013 | -19.98M |
| September 30, 2013 | -23.08M |
| June 30, 2013 | -26.68M |
| March 31, 2013 | -29.91M |
| December 31, 2012 | -29.82M |
| September 30, 2012 | -28.75M |
| June 30, 2012 | -27.54M |
| March 31, 2012 | -25.64M |
| December 31, 2011 | -25.52M |
Free Cash Flow Range, Past 5 Years
-16.52M
Minimum
Jun 2019
24.86M
Maximum
Jun 2021
8.488M
Average
10.76M
Median
Free Cash Flow Benchmarks
| ANI Pharmaceuticals Inc | 100.45M |
| Arbutus Biopharma Corp | -78.92M |
| Chimerix Inc | -64.44M |
| Karyopharm Therapeutics Inc | -92.72M |
| Y-mAbs Therapeutics Inc | -27.23M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 7.202M |
| Cash from Investing (Quarterly) | -25.45M |
| Cash from Financing (Quarterly) | 2.126M |
| Free Cash Flow Per Share (Quarterly) | -0.1416 |
| Free Cash Flow to Equity (Quarterly) | -6.815M |
| Free Cash Flow Yield | 0.09% |